Skip to content
healthcare.dev

Bivalirudin

NDC 67457-256, bivalirudin, injection, powder, lyophilized, for solution, from Mylan Institutional LLC.

Product NDC
67457-256
Status
Listed
Labeler
Mylan Institutional LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202471
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67457-256 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BIVALIRUDIN250 mg/5mL

Pharmacologic classes

Anti-coagulant [EPC]; Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]

Package NDCNDC-11Package
67457-256-106745702561010 VIAL, SINGLE-DOSE in 1 CARTON (67457-256-10) / 5 mL in 1 VIAL, SINGLE-DOSE (67457-256-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/95d150e7-f152-4091-b831-e469c9578a54
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67457-256

Use it

Look up 67457-256 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67457-256 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67457-256. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.